Hermann Eichler

7.1k total citations · 2 hit papers
127 papers, 5.3k citations indexed

About

Hermann Eichler is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Hermann Eichler has authored 127 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 29 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Hermann Eichler's work include Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (26 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Hermann Eichler is often cited by papers focused on Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (26 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Hermann Eichler collaborates with scholars based in Germany, United States and United Kingdom. Hermann Eichler's co-authors include Harald Klüter, Susanne Kern, Karen Bieback, Johannes Stoeve, A. Dugrillon, Víctor Jiménez‐Yuste, Peter Bugert, Robert Klamroth, W. Zieger and Pratima Chowdary and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Small.

In The Last Decade

Hermann Eichler

117 papers receiving 5.2k citations

Hit Papers

Comparative Analysis of Mesenchymal Stem Cells from Bone ... 2004 2026 2011 2018 2006 2004 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann Eichler Germany 26 3.1k 1.9k 1.3k 1.1k 619 127 5.3k
Cecilia Götherström Sweden 25 3.9k 1.3× 1.9k 1.0× 1.5k 1.2× 773 0.7× 531 0.9× 63 5.3k
Katharina Schallmoser Austria 33 2.2k 0.7× 1.3k 0.7× 1.5k 1.1× 823 0.7× 409 0.7× 78 4.2k
Amelia Bartholomew United States 27 3.6k 1.2× 2.1k 1.1× 1.2k 1.0× 789 0.7× 471 0.8× 62 5.3k
Dirk Strunk Austria 42 2.6k 0.8× 1.6k 0.9× 2.2k 1.7× 757 0.7× 528 0.9× 121 5.8k
Jean‐Jacques Lataillade France 31 1.8k 0.6× 995 0.5× 999 0.8× 685 0.6× 369 0.6× 79 3.9k
Helene Roelofs Netherlands 35 5.0k 1.6× 2.6k 1.4× 1.8k 1.4× 1.2k 1.1× 506 0.8× 76 7.2k
Mehmet Uzunel Sweden 34 3.6k 1.2× 1.6k 0.9× 1.3k 1.0× 2.1k 1.9× 369 0.6× 78 6.2k
Farida Djouad France 36 3.9k 1.3× 1.6k 0.9× 1.9k 1.5× 328 0.3× 481 0.8× 88 6.4k
Laurence Lagneaux Belgium 43 3.4k 1.1× 1.2k 0.7× 2.1k 1.6× 599 0.5× 299 0.5× 135 5.8k
Fermín Sánchez‐Guijo Spain 37 2.0k 0.7× 828 0.4× 1.2k 0.9× 1.3k 1.1× 186 0.3× 146 4.3k

Countries citing papers authored by Hermann Eichler

Since Specialization
Citations

This map shows the geographic impact of Hermann Eichler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Eichler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Eichler more than expected).

Fields of papers citing papers by Hermann Eichler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Eichler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Eichler. The network helps show where Hermann Eichler may publish in the future.

Co-authorship network of co-authors of Hermann Eichler

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann Eichler. A scholar is included among the top collaborators of Hermann Eichler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann Eichler. Hermann Eichler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobbelstein, Christiane, Robert Klamroth, Christina Hart, et al.. (2025). Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A. Blood Advances. 9(22). 5853–5860.
2.
Knowles, Lynn M., Constantin Lapa, Michael D. Menger, et al.. (2025). Fibroblast-activating protein as a biomarker for blood-induced joint inflammation in hemophilia. Blood. 146(Supplement 1). 1280–1280.
3.
Sachs, Ulrich J., Karolin Trautmann‐Grill, Christian Pfrepper, et al.. (2024). Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study. Research and Practice in Thrombosis and Haemostasis. 8(7). 102565–102565.
5.
Knowles, Lynn M., Stefan Linsler, Steffi Urbschat, et al.. (2024). Clotting Promotes Glioma Growth and Infiltration Through Activation of Focal Adhesion Kinase. Cancer Research Communications. 4(12). 3124–3136. 1 indexed citations
6.
Koch, Marcus, Thomas Kister, Hermann Eichler, et al.. (2024). Soft Synthetic Cells with Mobile Membrane Ligands for Ex Vivo Expansion of Therapy‐Relevant T Cell Phenotypes. Small. 20(37). e2401844–e2401844. 3 indexed citations
7.
Pfrepper, Christian, Robert Klamroth, Johannes Oldenburg, et al.. (2023). Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group. Hämostaseologie. 44(6). 466–471. 10 indexed citations
8.
Knowles, Lynn M., et al.. (2023). Activation of the Acute-Phase Response in Hemophilia. Thrombosis and Haemostasis. 123(9). 867–879. 4 indexed citations
9.
Young, Guy, Gary Benson, Hermann Eichler, et al.. (2023). OC 59.4 Health-Related Quality of Life, Treatment Burden and Patient Preference in Patients with Haemophilia A/B Without Inhibitors on Concizumab Prophylaxis: Results from the Phase 3 Explorer8 Study. Research and Practice in Thrombosis and Haemostasis. 7. 100427–100427. 1 indexed citations
10.
Pipe, Steven W., John P. Sheehan, Michiel Coppens, et al.. (2021). First-in-Human Dose-Finding Study of AAVhu37 Vector-Based Gene Therapy: BAY 2599023 Has Stable and Sustained Expression of FVIII over 2 Years. Blood. 138(Supplement 1). 3971–3971. 12 indexed citations
11.
Eichler, Hermann, Kerstin Weitmann, Wolfgang Hoffmann, et al.. (2020). Population-Based Analysis of the Impact of Demographics on the Current and Future Blood Supply in the Saarland. Transfusion Medicine and Hemotherapy. 48(3). 175–182. 4 indexed citations
12.
Holstein, Katharina, Paul Knöbl, Christiane Dobbelstein, et al.. (2017). Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study. Blood. 130. 22–22. 2 indexed citations
13.
Werwitzke, Sonja, Ulrich Geisen, Ulrike Nowak‐Göttl, et al.. (2016). Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study. Journal of Thrombosis and Haemostasis. 14(5). 940–947. 42 indexed citations
14.
Haspel, Richard L., Yulia Lin, Ranjeeta Mallick, et al.. (2014). Internal medicine resident knowledge of transfusion medicine: results from the BESTTEST international education needs assessment. Transfusion. 55(6). 1355–1361. 56 indexed citations
16.
Nguyen, Xuan Duc, Hermann Eichler, A. Dugrillon, et al.. (2003). Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. Journal of Immunological Methods. 275(1-2). 57–68. 49 indexed citations
17.
Nguyen, Xuan Duc, Hermann Eichler, Antje Sucker, et al.. (2002). Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients. Transfusion. 42(4). 428–432. 22 indexed citations
18.
Eichler, Hermann, et al.. (2000). Cord blood as a source of autologous RBCs for transfusion to preterm infants. Transfusion. 40(9). 1111–1117. 54 indexed citations
19.
Richter, Ekkehard, et al.. (1998). 5% Me2SO is sufficient to preserve stem cells derived from cord blood.. PubMed. 22 Suppl 1. S16–S16. 12 indexed citations
20.
Eichler, Hermann. (1993). Rechtssysteme der Zivilgesetzbücher : Vermächtnis und Aufgabe. P. Lang eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026